{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:59:42Z","timestamp":1791849582341,"version":"4.3.4"},"reference-count":76,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2013,10,6]],"date-time":"2013-10-06T00:00:00Z","timestamp":1381017600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100016557","name":"A+ Trust","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100016557","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001511","name":"Auckland Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001511","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,10,6]]},"abstract":"<jats:title>Summary<\/jats:title>\n               <jats:p>Common variable immune deficiency (CVID) is the most frequent symptomatic primary immune deficiency in adults. The standard of care is intravenous immunoglobulin (IVIG) or subcutaneous immunoglobulin (scIG) therapy. The cause of CVID is currently unknown, and there is no universally accepted definition of CVID. This creates problems in determining which patients will benefit from IVIG\/scIG treatment. In this paper, we review the difficulties with the commonly used European Society of Immune Deficiencies (ESID) and the Pan American Group for Immune Deficiency (PAGID) definition of CVID. We propose new criteria for the diagnosis of CVID, which are based on recent scientific discoveries. Improved diagnostic precision will assist with treatment decisions including IVIG\/scIG replacement. We suggest that asymptomatic patients with mild hypogammaglobulinaemia are termed hypogammaglobulinaemia of uncertain significance (HGUS). These patients require long-term follow-up, as some will evolve into CVID.<\/jats:p>","DOI":"10.1111\/cei.12178","type":"journal-article","created":{"date-parts":[[2013,7,17]],"date-time":"2013-07-17T10:43:45Z","timestamp":1374057825000},"page":"203-211","source":"Crossref","is-referenced-by-count":199,"title":["New diagnostic criteria for common variable immune deficiency (CVID), which may assist with decisions to treat with intravenous or subcutaneous immunoglobulin"],"prefix":"10.1093","volume":"174","author":[{"given":"R","family":"Ameratunga","sequence":"first","affiliation":[{"name":"Department of Virology and Immunology, Auckland City Hospital, Auckland, New Zealand"},{"name":"Department of Clinical Immunology, Auckland City Hospital, Auckland, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S-T","family":"Woon","sequence":"additional","affiliation":[{"name":"Department of Virology and Immunology, Auckland City Hospital, Auckland, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Gillis","sequence":"additional","affiliation":[{"name":"University of Queensland, Brisbane, Qld, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W","family":"Koopmans","sequence":"additional","affiliation":[{"name":"Department of Virology and Immunology, Auckland City Hospital, Auckland, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Steele","sequence":"additional","affiliation":[{"name":"Department of Virology and Immunology, Auckland City Hospital, Auckland, New Zealand"},{"name":"Wellington Hospital, Wellington, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2013,10,6]]},"reference":[{"key":"2021122009592287500_cei12178-bib-0001","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s10875-007-9105-z","article-title":"Primary immunodeficiency diseases in Australia and New Zealand","volume":"27","author":"Kirkpatrick","year":"2007","journal-title":"J Clin Immunol"},{"key":"2021122009592287500_cei12178-bib-0002","doi-asserted-by":"crossref","first-page":"788","DOI":"10.3346\/jkms.2012.27.7.788","article-title":"Prevalence of primary immunodeficiency in Korea","volume":"27","author":"Rhim","year":"2012","journal-title":"J Korean Med Sci"},{"key":"2021122009592287500_cei12178-bib-0003","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1007\/s10875-011-9594-7","article-title":"Nationwide survey of patients with primary immunodeficiency diseases in Japan","volume":"31","author":"Ishimura","year":"2011","journal-title":"J Clin Immunol"},{"key":"2021122009592287500_cei12178-bib-0004","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1006\/clim.1999.4725","article-title":"Common variable immunodeficiency: clinical and immunological features of 248 patients","volume":"92","author":"Cunningham-Rundles","year":"1999","journal-title":"Clin Immunol"},{"key":"2021122009592287500_cei12178-bib-0005","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1749-6632.2011.06338.x","article-title":"Perspectives on common variable immune deficiency","volume":"1246","author":"Park","year":"2011","journal-title":"Ann NY Acad Sci"},{"key":"2021122009592287500_cei12178-bib-0006","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1056\/NEJMoa051568","article-title":"An antibody-deficiency syndrome due to mutations in the CD19 gene","volume":"354","author":"van Zelm","year":"2006","journal-title":"N Engl J Med"},{"key":"2021122009592287500_cei12178-bib-0007","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/ni902","article-title":"Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency","volume":"4","author":"Grimbacher","year":"2003","journal-title":"Nat Immunol"},{"key":"2021122009592287500_cei12178-bib-0008","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1172\/JCI40231","article-title":"CD20 deficiency in humans results in impaired T cell-independent antibody responses","volume":"120","author":"Kuijpers","year":"2010","journal-title":"J Clin Invest"},{"key":"2021122009592287500_cei12178-bib-0009","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1172\/JCI39748","article-title":"CD81 gene defect in humans disrupts CD19 complex formation and leads to antibody deficiency","volume":"120","author":"van Zelm","year":"2010","journal-title":"J Clin Invest"},{"key":"2021122009592287500_cei12178-bib-0010","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3389\/fimmu.2011.00054","article-title":"Primary immunodeficiency diseases: an update on the classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency","volume":"2","author":"Al-Herz","year":"2011","journal-title":"Front Immunol"},{"key":"2021122009592287500_cei12178-bib-0011","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/ng0407-429","article-title":"Reexamining the role of TACI coding variants in common variable immunodeficiency and selective IgA deficiency","volume":"39","author":"Pan-Hammarstrom","year":"2007","journal-title":"Nat Genet"},{"key":"2021122009592287500_cei12178-bib-0012","doi-asserted-by":"crossref","first-page":"7193","DOI":"10.1073\/pnas.0700815104","article-title":"Role for Msh5 in the regulation of Ig class switch recombination","volume":"104","author":"Sekine","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"2021122009592287500_cei12178-bib-0013","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s10875-012-9793-x","article-title":"Clinical variability of family members with the C104R mutation in transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI)","volume":"33","author":"Koopmans","year":"2013","journal-title":"J Clin Immunol"},{"key":"2021122009592287500_cei12178-bib-0014","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1006\/clim.1999.4799","article-title":"Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies)","volume":"93","author":"Conley","year":"1999","journal-title":"Clin Immunol"},{"key":"2021122009592287500_cei12178-bib-0015","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s10875-011-9511-0","article-title":"Effectiveness of immunoglobulin replacement therapy on clinical outcome in patients with primary antibody deficiencies: results from a multicenter prospective cohort study","volume":"31","author":"Quinti","year":"2011","journal-title":"J Clin Immunol"},{"key":"2021122009592287500_cei12178-bib-0016","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.2174\/138161211798157540","article-title":"Update on intravenous immunoglobulins (IVIg) mechanisms of action and off-label use in autoimmune diseases","volume":"17","author":"Katz","year":"2011","journal-title":"Curr Pharm Des"},{"key":"2021122009592287500_cei12178-bib-0017","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1056\/NEJMra1009433","article-title":"Intravenous immune globulin in autoimmune and inflammatory diseases","volume":"367","author":"Gelfand","year":"2012","journal-title":"N Engl J Med"},{"key":"2021122009592287500_cei12178-bib-0018","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1749-6632.2011.06238.x","article-title":"Primary immune deficiency disorders in the South Pacific: the clinical utility of a customized genetic testing program in New Zealand","volume":"1238","author":"Ameratunga","year":"2011","journal-title":"Ann NY Acad Sci"},{"key":"2021122009592287500_cei12178-bib-0019","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.jaci.2013.02.028","article-title":"Controversies in IgG replacement therapy in patients with antibody deficiency diseases","volume":"131","author":"Gelfand","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"2021122009592287500_cei12178-bib-0020","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1016\/j.jaci.2013.01.036","article-title":"Treatment of hypogammaglobulinemia in adults: a scoring system to guide decisions on immunoglobulin replacement","volume":"131","author":"Agarwal","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"2021122009592287500_cei12178-bib-0021","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1365-2141.2009.07669.x","article-title":"Update in understanding common variable immunodeficiency disorders (CVIDs) and the management of patients with these conditions","volume":"145","author":"Chapel","year":"2009","journal-title":"Br J Haematol"},{"key":"2021122009592287500_cei12178-bib-0022","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/(SICI)1098-2825(1998)12:6<363::AID-JCLA6>3.0.CO;2-X","article-title":"Reference distributions for immunoglobulins A, G, and M: a practical, simple, and clinically relevant approach in a large cohort","volume":"12","author":"Ritchie","year":"1998","journal-title":"J Clin Lab Anal"},{"key":"2021122009592287500_cei12178-bib-0023","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jaci.2012.07.002","article-title":"Use and interpretation of diagnostic vaccination in primary immunodeficiency: a working group report of the Basic and Clinical Immunology Interest Section of the American Academy of Allergy, Asthma and Immunology","volume":"130","author":"Orange","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"2021122009592287500_cei12178-bib-0024","first-page":"U914","article-title":"The assessment and management of primary antibody deficiency","volume":"117","author":"Empson","year":"2004","journal-title":"NZ Med J"},{"key":"2021122009592287500_cei12178-bib-0025","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.clim.2007.04.011","article-title":"Active vaccination in patients with common variable immunodeficiency (CVID)","volume":"124","author":"Goldacker","year":"2007","journal-title":"Clin Immunol"},{"key":"2021122009592287500_cei12178-bib-0026","doi-asserted-by":"crossref","first-page":"5464","DOI":"10.1016\/j.vaccine.2012.06.073","article-title":"A randomised, double-blind, non-inferiority clinical trial on the safety and immunogenicity of a tetanus, diphtheria and monocomponent acellular pertussis (TdaP) vaccine in comparison to a tetanus and diphtheria (Td) vaccine when given as booster vaccinations to healthy adults","volume":"30","author":"Thierry-Carstensen","year":"2012","journal-title":"Vaccine"},{"key":"2021122009592287500_cei12178-bib-0027","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1128\/CVI.00101-12","article-title":"Immune response to Haemophilus influenzae type B vaccination in patients with chronic renal failure","volume":"19","author":"Hawdon","year":"2012","journal-title":"Clin Vaccine Immunol"},{"key":"2021122009592287500_cei12178-bib-0028","doi-asserted-by":"crossref","first-page":"24","DOI":"10.4161\/hv.2.1.2445","article-title":"Immunogenicity and reactogenicity to Haemophilus influenzae type B (Hib) conjugate vaccine among rural Alaska adults","volume":"2","author":"Dentinger","year":"2006","journal-title":"Hum Vaccin"},{"key":"2021122009592287500_cei12178-bib-0029","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1440-1754.1997.tb01016.x","article-title":"The immunogenicity of Haemophilus influenzae: meningococcal protein conjugate vaccine in Polynesian and non-Polynesian New Zealand infants","volume":"33","author":"Ameratunga","year":"1997","journal-title":"J Paediatr Child Health"},{"key":"2021122009592287500_cei12178-bib-0030","doi-asserted-by":"crossref","first-page":"pii: 20313","DOI":"10.2807\/ese.17.46.20313-en","article-title":"Haemophilus influenzae serotype B (Hib) seroprevalence in England and Wales in 2009","volume":"17","author":"Ladhani","year":"2012","journal-title":"Euro Surveill"},{"key":"2021122009592287500_cei12178-bib-0031","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S1473-3099(07)70210-4","article-title":"Combined schedules of pneumococcal conjugate and polysaccharide vaccines: is hyporesponsiveness an issue?","volume":"7","author":"O'Brien","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"2021122009592287500_cei12178-bib-0032","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0022-3476(78)80417-X","article-title":"Transient hypogammaglobulinemia of infancy: review of the literature, clinical and immunologic features of 11 new cases, and long-term follow-up","volume":"92","author":"Tiller","year":"1978","journal-title":"J Pediatr"},{"key":"2021122009592287500_cei12178-bib-0033","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1471-2334-10-60","article-title":"The effect of age on the response to the pneumococcal polysaccharide vaccine","volume":"10","author":"Lee","year":"2010","journal-title":"BMC Infect Dis"},{"key":"2021122009592287500_cei12178-bib-0034","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1128\/CVI.13.3.356-360.2006","article-title":"Critical differences between pneumococcal polysaccharide enzyme-linked immunosorbent assays with and without 22F inhibition at low antibody concentrations in pediatric sera","volume":"13","author":"Henckaerts","year":"2006","journal-title":"Clin Vaccine Immunol"},{"key":"2021122009592287500_cei12178-bib-0035","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1128\/CDLI.8.2.266-272.2001","article-title":"Pneumococcal type 22f polysaccharide absorption improves the specificity of a pneumococcal\u2013polysaccharide enzyme-linked immunosorbent assay","volume":"8","author":"Concepcion","year":"2001","journal-title":"Clin Diagn Lab Immunol"},{"key":"2021122009592287500_cei12178-bib-0036","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jaci.2012.04.028","article-title":"Vaccines in the assessment of patients for immune deficiency","volume":"130","author":"Ballow","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"2021122009592287500_cei12178-bib-0037","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s10875-012-9806-9","article-title":"Serotype-specific anti-pneumococcal IgG and immune competence: critical differences in interpretation criteria when different methods are used","volume":"33","author":"Balloch","year":"2013","journal-title":"J Clin Immunol"},{"key":"2021122009592287500_cei12178-bib-0038","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.vaccine.2010.10.046","article-title":"Opsonophagocytic activity following a reduced dose 7-valent pneumococcal conjugate vaccine infant primary series and 23-valent pneumococcal polysaccharide vaccine at 12 months of age","volume":"29","author":"Russell","year":"2011","journal-title":"Vaccine"},{"key":"2021122009592287500_cei12178-bib-0039","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1128\/CVI.13.2.165-169.2006","article-title":"Use of opsonophagocytosis for serological evaluation of pneumococcal vaccines","volume":"13","author":"Romero-Steiner","year":"2006","journal-title":"Clin Vaccine Immunol"},{"key":"2021122009592287500_cei12178-bib-0040","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1007\/s10875-012-9856-z","article-title":"Quantification of IgM and IgA anti-pneumococcal capsular polysaccharides by a new ELISA assay: a valuable diagnostic and prognostic tool for common variable immunodeficiency","volume":"33","author":"Cavaliere","year":"2013","journal-title":"J Clin Immunol"},{"key":"2021122009592287500_cei12178-bib-0041","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0091-6749(98)70089-2","article-title":"Influence of age on the response to Streptococcus pneumoniae vaccine in patients with recurrent infections and normal immunoglobulin concentrations","volume":"102","author":"Sorensen","year":"1998","journal-title":"J Allergy Clin Immunol"},{"key":"2021122009592287500_cei12178-bib-0042","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S1081-1206(10)61142-8","article-title":"Practice parameter for the diagnosis and management of primary immunodeficiency","volume":"94","author":"Bonilla","year":"2005","journal-title":"Ann Allergy Asthma Immunol"},{"key":"2021122009592287500_cei12178-bib-0043","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S1081-1206(10)60572-8","article-title":"Assessment and clinical interpretation of polysaccharide antibody responses","volume":"99","author":"Paris","year":"2007","journal-title":"Ann Allergy Asthma Immunol"},{"key":"2021122009592287500_cei12178-bib-0044","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1016\/S0264-410X(03)00230-5","article-title":"Serological criteria for evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infants","volume":"21","author":"Jodar","year":"2003","journal-title":"Vaccine"},{"key":"2021122009592287500_cei12178-bib-0045","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1016\/S0264-410X(03)00025-2","article-title":"Correlates of immunity for pneumococcal conjugate vaccines","volume":"21","author":"Lee","year":"2003","journal-title":"Vaccine"},{"key":"2021122009592287500_cei12178-bib-0046","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1086\/422531","article-title":"Concentration of antipneumococcal antibodies as a serological correlate of protection: an application to acute otitis media","volume":"190","author":"Jokinen","year":"2004","journal-title":"J Infect Dis"},{"key":"2021122009592287500_cei12178-bib-0047","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jaci.2008.09.021","article-title":"Antibody response to pneumococcal vaccination as a function of preimmunization titer","volume":"123","author":"Hare","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"2021122009592287500_cei12178-bib-0048","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1365-2249.2004.02439.x","article-title":"Development of an anti-Salmonella typhi Vi ELISA: assessment of immunocompetence in healthy donors","volume":"136","author":"Ferry","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"2021122009592287500_cei12178-bib-0049","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1128\/CVI.00389-09","article-title":"Serum bactericidal antibody response 1 year after meningococcal polysaccharide vaccination of patients with common variable immunodeficiency","volume":"17","author":"Rezaei","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"2021122009592287500_cei12178-bib-0050","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1023\/B:JOCI.0000010429.36461.6b","article-title":"Vaccination with rabies to study the humoral and cellular immune response to a T-cell dependent neoantigen in man","volume":"23","author":"Brinkman","year":"2003","journal-title":"J Clin Immunol"},{"key":"2021122009592287500_cei12178-bib-0051","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1172\/JCI106756","article-title":"Immunologic responses to bacteriophage phi-X 174 in immunodeficiency diseases","volume":"50","author":"Ochs","year":"1971","journal-title":"J Clin Invest"},{"key":"2021122009592287500_cei12178-bib-0052","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S1081-1206(10)60665-5","article-title":"Assessment and clinical interpretation of reduced IgG values","volume":"99","author":"Agarwal","year":"2007","journal-title":"Ann Allergy Asthma Immunol"},{"key":"2021122009592287500_cei12178-bib-0053","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1212\/01.WNL.0000113754.29225.5D","article-title":"Lamotrigine-induced common variable immune deficiency","volume":"62","author":"Smith","year":"2004","journal-title":"Neurology"},{"key":"2021122009592287500_cei12178-bib-0054","first-page":"31","article-title":"Primary hypogammaglobulinaemia: a survey of clinical manifestations and complications","volume":"86","author":"Hermaszewski","year":"1993","journal-title":"Q J Med"},{"key":"2021122009592287500_cei12178-bib-0055","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s10875-007-9075-1","article-title":"Long-term follow-up and outcome of a large cohort of patients with common variable immunodeficiency","volume":"27","author":"Quinti","year":"2007","journal-title":"J Clin Immunol"},{"key":"2021122009592287500_cei12178-bib-0056","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1182\/blood-2007-11-124545","article-title":"Common variable immunodeficiency disorders: division into distinct clinical phenotypes","volume":"112","author":"Chapel","year":"2008","journal-title":"Blood"},{"key":"2021122009592287500_cei12178-bib-0057","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1086\/587669","article-title":"Infections in 252 patients with common variable immunodeficiency","volume":"46","author":"Oksenhendler","year":"2008","journal-title":"Clin Infect Dis"},{"key":"2021122009592287500_cei12178-bib-0058","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.autrev.2005.10.002","article-title":"Inflammatory and autoimmune complications of common variable immune deficiency","volume":"5","author":"Knight","year":"2006","journal-title":"Autoimmun Rev"},{"key":"2021122009592287500_cei12178-bib-0059","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1182\/blood-2007-06-091744","article-title":"The EUROclass trial: defining subgroups in common variable immunodeficiency","volume":"111","author":"Wehr","year":"2008","journal-title":"Blood"},{"key":"2021122009592287500_cei12178-bib-0060","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.1365-2249.2009.04062.x","article-title":"Immunological and clinical profile of adult patients with selective immunoglobulin subclass deficiency: response to intravenous immunoglobulin therapy","volume":"159","author":"Abrahamian","year":"2010","journal-title":"Clin Exp Immunol"},{"key":"2021122009592287500_cei12178-bib-0061","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1080\/00365540600951192","article-title":"Immunoglobulin prophylaxis in 350 adults with IgG subclass deficiency and recurrent respiratory tract infections: a long-term follow-up","volume":"39","author":"Olinder-Nielsen","year":"2007","journal-title":"Scand J Infect Dis"},{"key":"2021122009592287500_cei12178-bib-0062","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1086\/649839","article-title":"Safety and antibody response, including antibody persistence for 5 years, after primary vaccination or revaccination with pneumococcal polysaccharide vaccine in middle-aged and older adults","volume":"201","author":"Musher","year":"2010","journal-title":"J Infect Dis"},{"key":"2021122009592287500_cei12178-bib-0063","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1182\/blood-2008-02-141937","article-title":"Relevance of biallelic versus monoallelic TNFRSF13B mutations in distinguishing disease-causing from risk-increasing TNFRSF13B variants in antibody deficiency syndromes","volume":"113","author":"Salzer","year":"2009","journal-title":"Blood"},{"key":"2021122009592287500_cei12178-bib-0064","first-page":"203","article-title":"Lymphocytic interstitial pneumonia of common variable immunodeficiency","volume":"60","author":"Popa","year":"1988","journal-title":"Ann Allergy"},{"key":"2021122009592287500_cei12178-bib-0065","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1080\/713688933","article-title":"The simultaneous presentation of sarcoidosis and common variable immune deficiency","volume":"32","author":"Ameratunga","year":"2000","journal-title":"Pathology"},{"key":"2021122009592287500_cei12178-bib-0066","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/00005792-199609000-00002","article-title":"Sarcoidosis and common variable immunodeficiency. Report of 8 cases and review of the literature","volume":"75","author":"Fasano","year":"1996","journal-title":"Medicine (Balt)"},{"key":"2021122009592287500_cei12178-bib-0067","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1007\/s10875-013-9873-6","article-title":"Nodular regenerative hyperplasia in common variable immunodeficiency","volume":"33","author":"Fuss","year":"2013","journal-title":"J Clin Immunol"},{"key":"2021122009592287500_cei12178-bib-0068","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jhep.2007.08.011","article-title":"Nodular regenerative hyperplasia: the main liver disease in patients with primary hypogammaglobulinemia and hepatic abnormalities","volume":"48","author":"Malamut","year":"2008","journal-title":"J Hepatol"},{"key":"2021122009592287500_cei12178-bib-0069","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1572-0241.2003.07159.x","article-title":"Duodenal pathology and clinical\u2013immunological implications in common variable immunodeficiency patients","volume":"98","author":"Luzi","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"2021122009592287500_cei12178-bib-0070","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1038\/ajg.2010.214","article-title":"The enteropathy associated with common variable immunodeficiency: the delineated frontiers with celiac disease","volume":"105","author":"Malamut","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"2021122009592287500_cei12178-bib-0071","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/ibd.21376","article-title":"Characterization of immunologic defects in patients with common variable immunodeficiency (CVID) with intestinal disease","volume":"17","author":"Agarwal","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"2021122009592287500_cei12178-bib-0072","doi-asserted-by":"crossref","first-page":"135","DOI":"10.4104\/pcrj.2011.00007","article-title":"Primary care summary of the British Thoracic Society Guideline on the management of non-cystic fibrosis bronchiectasis","volume":"20","author":"Hill","year":"2011","journal-title":"Prim Care Respir J"},{"key":"2021122009592287500_cei12178-bib-0073","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/sji.12028","article-title":"Variability of memory B cell markers in a cohort of common variable immune deficiency patients over six months","volume":"77","author":"Koopmans","year":"2013","journal-title":"Scand J Immunol"},{"key":"2021122009592287500_cei12178-bib-0074","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/j.jaci.2011.02.039","article-title":"Genome-wide association identifies diverse causes of common variable immunodeficiency","volume":"127","author":"Orange","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"2021122009592287500_cei12178-bib-0075","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1309\/AJCPEIILH2C0WFYE","article-title":"The significance of duodenal mucosal atrophy in patients with common variable immunodeficiency: a clinical and histopathologic study","volume":"138","author":"Biagi","year":"2012","journal-title":"Am J Clin Pathol"},{"key":"2021122009592287500_cei12178-bib-0076","doi-asserted-by":"crossref","DOI":"10.1186\/1710-1492-9-36","article-title":"Hypogammaglobulinemia factitia: Munchausen syndrome masquerading as common variable immune deficiency","volume-title":"Allergy Asthma Clin Immunol","author":"Ameratunga","year":"2013"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fcei.12178","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/174\/2\/203\/41788732\/cei12178.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/174\/2\/203\/41788732\/cei12178.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T16:25:09Z","timestamp":1641054309000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/174\/2\/203\/6421018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,6]]},"references-count":76,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2013,10,6]]},"published-print":{"date-parts":[[2013,10,6]]}},"URL":"https:\/\/doi.org\/10.1111\/cei.12178","relation":{},"ISSN":["1365-2249","0009-9104"],"issn-type":[{"value":"1365-2249","type":"electronic"},{"value":"0009-9104","type":"print"}],"subject":[],"published-other":{"date-parts":[[2013,11]]},"published":{"date-parts":[[2013,10,6]]}}}